US Stock MarketDetailed Quotes
GPCR Structure Therapeutics
- 34.215
- +0.205+0.60%
Trading Nov 26 12:08 ET
1.96BMarket Cap-17718P/E (TTM)
35.280High33.783Low188.01KVolume34.370Open34.010Pre Close6.47MTurnover0.37%Turnover RatioLossP/E (Static)57.26MShares66.38052wk High2.18P/B1.75BFloat Cap26.61052wk Low--Dividend TTM51.24MShs Float75.017Historical High--Div YieldTTM4.40%Amplitude20.800Historical Low34.439Avg Price1Lot Size
About Structure Therapeutics Company
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in South San Francisco, CA.
Company Profile
SymbolGPCR
Company NameStructure Therapeutics
Listing DateFeb 3, 2023
Issue Price15.00
Founded2019
CEOProfessor Raymond C. Stevens, PhD
MarketNASDAQ
Employees93
Securities TypeDR
ADS Ratio1.0 : 3.0
Fiscal Year Ends12-31
Address601 Gateway Boulevard,Suite 900
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-457-1978
Websitehttp://www.structuretx.com
Company Executives
- Name
- Position
- Salary
- Professor Raymond C. Stevens, PhD
- Director and Chief Executive Officer
- 747.33K
- Dr. Blai Coll
- Chief Medical Officer
- --
- Dr. Yingli Ma, PhD
- Chief Technology Officer
- 1.24M
- Ashley F. Hall, J.D.
- Chief Development Officer
- --
- Jun Yoon
- Principal Accounting Officer and Chief Financial Officer
- --
- Dr. Xichen Lin, PhD
- Chief Scientific Officer
- --
- Daniel G. Welch
- Chairman of the Board
- 2.42M
- Sharon E. Tetlow
- Independent Director
- 213.84K
- Dr. Joanne Waldstreicher, M.D.
- Independent Director
- 218.82K
- Angus Charles Russell
- Independent Director
- --
- Eric L. Dobmeier
- Independent Director
- 218.82K
- Dr. Ted W. Love, M.D.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
